Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Weight Loss 1 Preleukemia 1 Ovarian Neoplasms 1 Osteochondroma 1 Obesity 1 Non-alcoholic Fatty Liver Disease 1 Nevus, Epithelioid and Spindle Cell 1 Myelodysplastic Syndromes 1 Malnutrition 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Glioblastoma 1 Giant Cell Tumors 1 Gastrointestinal Neoplasms 1 Fibrosis 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Carcinoma, Merkel Cell 1 Carcinoma, Lobular 1 Carcinoma in Situ 1 Barrett Esophagus 1

Interventions

pembrolizumab 12 Radiotherapy 9 avelumab 8 Nivolumab 8 cemiplimab 4 Radiation 4 Ipilimumab 4 poly ICLC 3 atezolizumab 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Etoposide 3 Cyclophosphamide 3 talimogene laherparepvec 2 lutetium Lu 177 dotatate 2 fludarabine phosphate 2 fludarabine 2 durvalumab 2 aldesleukin 2 Interferon-beta 2 Immunoglobulin G 2 Immune Checkpoint Inhibitors 2 Cisplatin 2 Carboplatin 2 Biopsy 2 veliparib 1 vatalanib 1 tremelimumab 1 tocilizumab 1 temsirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Merkel Cell × Sampling Studies × Clear all

NCT04705389 2021-05-18

SUMMERTIME

University Hospital, Tours

Phase NA Unknown

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡